Abstract
Objective
With the increase in lung cancer patients over 80 years of age, lobectomy with mediastinal lymph node dissection is often performed in patients in a good general condition. However, the age limit for this procedure has not yet been determined. In this study, we examined the safety, therapeutic results, and prognosis of surgical treatment for lung cancer patients over 85 years of age.
Methods
Among the 4446 lung cancer patients who underwent surgery at our hospital from January 1997 to March 2019, we assessed 320 patients (7.2%, Group A, aged 80–84 years) and 74 patients (1.7%, Group B, aged over 85 years).
Results
The median age of the patients in Group B was 86 years. Compared to Group A, Group B had significantly more patients with a history of ischemic heart disease, lower pack-year smoking, and lobectomy and lobectomy less resection (reduced surgery), and a shorter operation time (P < 0.05). There was no significant difference between the two groups in terms of postoperative complications. There was no significant difference in survival rate and prognosis between the two groups, and the 2-, 3-, and 5-year survival rates were 79.0%, 74.7%, and 53.6%, respectively, in Group B. In Group B sex (female) and early stage of cancer were independent prognostic factors of non-small cell lung cancer (stage I).
Conclusions
In a limited number of patients, surgical resection in patients aged over 85 years was safely performed, and the survival of these patients was comparable to those aged 80–84 years.
Similar content being viewed by others
References
National Institute of Aging: Global aging. https://www.nia.nih.gov/sites/default/files/2017-06/global_health_aging.pdf. Accessed 2 Aug 2019.
Evans JR, Fletcher AE, Wormald RP, Ng ES, Stirling S, Smeeth L, et al. Prevalence of visual impairment in people aged 75 years and older in Britain results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol. 2002;86:795–800. https://doi.org/10.1136/bjo.86.7.795.
Desai M, Pratt LA, Lentzner H, Robinson KN. Trend in vision and hearing among older Americans. Aging trends. Hyattsville. MD: National Center for Health Statistics; 2001.
Butler AA, Menant JC, Tiedemann AC, Lord SR. Age and gender differences in seven tests of functional mobility. J Neuroeng Rehabil. 2009;6:31. https://doi.org/10.1186/1743-0003-6-31.
He W, Larsen LJ. U.S. Census Bureau, American Community Survey reports, ACS-29, Older Americans with a disability: 2008–2012. Washington, DC: U.S. Government Printing Office; 2014.
Dodds RM, Granic A, Davies K, Kirkwood TB, Jagger C, Sayer AA. Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85 + study. J Cachexia Sarcopenia Muscle. 2017;8:229–37. https://doi.org/10.1002/jcsm.12157.
Goya T, Asamura H, Yoshimura H, et al. Prognosis of 6644 resected non-small cell lung cancer in Japan: a Japanese lung cancer registry study. Lung Cancer. 2005;50:227–34.
Zhang Z, Mostofian F, Ivanovic J, et al. All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection. J Thorac Cardiovasc Surg. 2018;15:798–807.
Saji H, Ueno T, Nakamura H, et al. A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303. Eur J Cardiothorac Surg. 2018;53:835–41.
Rueth NM, Parson HM, Habermann EB, et al. The long-term impact of surgical complications after resection of stage I non-small cell lung cancer: a population-based survival analysis. Ann Surg. 2011;254:368–74.
Farjah F, Backhus L, Cheng A, et al. Failure to rescue and pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2015;149:1365–71.
Bernard A, Rivera CM, Pages PB, et al. Risk model of in-hospital mortality after pulmonary resection for cancer: a national database of the French Society of Thoracic and Cardiovascular Surgery (Epithor). J Thorac Cardiovasc Surg. 2011;141:449–58.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Bejr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.
Sobin LH, Gospodarowicz MK, Wittekind C. Lung and pleural tumors: UICC International Union against cancer TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009. p. 138–146.
Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetic of tumours of the lung, pleura, thymus and heart: World Health Organization classification of tumours. Lyon: IARC Press; 2004. p. 9–124.
Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol. 2009;4(10):1247–53.
Miura N, Kohno M, Ito K, Senba M, Kajiwara K, Hamaguchi N, et al. Lung cancer surgery in patients aged 80 years or older: an analysis of risk factors, morbidity, and mortality. Gen Thorac Cardiovasc Surg. 2015;63(7):401–5.
Schulkes KJG, Pouw CAM, Driessen EJM, van Elden LJR, van den Bos F, Janssen-Heijnen MLG, et al. Lung cancer in the oldest old: a nation-wide study in the Netherlands. Lung. 2017;195(5):627–34.
Hino H, Karasaki T, Yoshida Y, Fukami T, Sano A, Tanaka M, et al. Competing risk analysis in lung cancer patients over 80 years old undergoing surgery. World J Surg. 2019;43(7):1857–66.
Pagès PB, Mariet AS, Pforr A, Cottenet J, Madelaine L, Abou-Hanna H, et al. Does age over 80 years have to be a contraindication for lung cancer surgery—a nationwide database study. J Thorac Dis. 2018;10(8):4764–73.
Detillon DD, Veen EJ. Postoperative outcome after pulmonary surgery for non-small cell lung cancer in elderly patients. Ann Thorac Surg. 2018;105(1):287–93.
Shinohara S, Kobayashi K, Kasahara C, Onitsuka T, Matsuo M, Nakagawa M, et al. Long-term impact of complications after lung resections in non-small cell lung cancer. J Thorac Dis. 2019;11(5):2024–33.
Suzuki K, Saji H, Aokage K, Watanabe S, Okada M, Mizusawa J, et al. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J Thorac Cardiovasc Surg. 2019;158(3):895–907.
Kreinbrink P, Blumenfeld P, Tolekidis G, et al. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥ 80 years old): extremely safe and effective. J Geriatr Oncol. 2017;8(5):351–5.
Vansteenkiste J, De Ruysscher D, Eberhardt WE, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2013;24(Suppl 6):ci89–98.
Acknowledgements
We give special thanks to Dr. Kazuhiro Suzuki, Dr. Akihiro Hotta and Dr, Kazuhiro Ando for their great help for the CT diagnosis on this manuscript. No financial support for the study was provided by any organization.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ichinokawa, H., Takamochi, K., Fukui, M. et al. Surgical results and prognosis of lung cancer in elderly Japanese patients aged over 85 years: comparison with patients aged 80–84 years. Gen Thorac Cardiovasc Surg 69, 67–75 (2021). https://doi.org/10.1007/s11748-020-01426-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-020-01426-y